The results suggested that SCH could increase the indexes of the thymus and spleen, decrease the levels of serum ALT and AST, increase the contents of serum IgG and small intestinal sIgA, and reduce the damage to the small intestine and colon. The gene discussed is GPT; the disease is spindle cell hemangioma.